Community medicines
Number of funded prescriptions dispensed in 2022/2023 financial year.
| Rank | Medicine | Therapeutic group | 2023 |
|---|---|---|---|
| 1 | Paracetamol | Analgesics | 3,460,000 |
| 2 | Atorvastatin | Cardiovascular | 1,840,000 |
| 3 | Omeprazole | Alimentary | 1,690,000 |
| 4 | Amoxicillin | Anti-infectives | 1,230,000 |
| 5 | Ibuprofen | Analgesics | 1,200,000 |
| 6 | Colecalciferol | Musculoskeletal | 1,110,000 |
| 7 | Aspirin | Antithrombotics | 1,100,000 |
| 8 | Metoprolol succinate | Cardiovascular | 920,000 |
| 9 | Salbutamol | Respiratory | 860,000 |
| 10 | Levothyroxine | Hormones | 710,000 |
| 11 | Prednisone | Hormones | 700,000 |
| 12 | Cetirizine hydrochloride | Antihistamines | 690,000 |
| 13 | Amlodipine | Cardiovascular | 680,000 |
| 14 | Candesartan cilexetil | Cardiovascular | 650,000 |
| 15 | Zopiclone | Nervous System | 640,000 |
| 16 | Loratadine | Antihistamines | 590,000 |
| 17 | Docusate sodium with sennosides | Laxatives | 590,000 |
| 18 | Metformin hydrochloride | Diabetes | 580,000 |
| 19 | Fluticasone propionate | Nasal Preparations | 560,000 |
| 20 | Celecoxib | Non-Steroidal Anti-Inflammatory Drugs | 550,000 |
| Total | 20,350,000 |